Baillie Gifford & CO Sorrento Therapeutics, Inc. Transaction History

Baillie Gifford & CO

  • $131 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 27, 2022
SELL
$1.51 - $2.88 $910 - $1,736
-603 Reduced 13.98%
3,711 $6,000
Q3 2021

Oct 19, 2021
SELL
$7.41 - $10.99 $6,209 - $9,209
-838 Reduced 16.27%
4,314 $33,000
Q2 2021

Aug 02, 2021
SELL
$6.35 - $10.0 $2,406 - $3,790
-379 Reduced 6.85%
5,152 $50,000
Q1 2021

May 06, 2021
BUY
$7.03 - $16.51 $2,966 - $6,967
422 Added 8.26%
5,531 $46,000
Q4 2020

Feb 10, 2021
BUY
$5.76 - $11.95 $29,427 - $61,052
5,109 New
5,109 $35,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email